AMENDMENT TO LOCK-UP AGREEMENT August 15, 2007Lock-Up Agreement • September 20th, 2007 • Osiris Therapeutics, Inc. • Biological products, (no disgnostic substances)
Reference is made to that certain Lock-Up Agreement dated October 30, 2006 (the “Original Agreement”) by Peter Friedli, Venturetec, Inc., and U.S. Venture 05, Inc, to and for the benefit of Osiris Therapeutics, Inc. (the “Company”), and pursuant to which Peter Friedli, Venturetec, Inc. and U.S. Venture 05, Inc. agreed, among other things, not to, directly or indirectly, offer, sell, contract to sell (including any short sales), grant any option to purchase, or otherwise to dispose of, any shares of common stock, par value $0.001 per share, of the Company, or to enter into any Hedging Transaction (as defined in the Original Agreement) relating to the common stock of the Company, during the Lock-Up Period (defined in the Original Agreement as commencing on October 30, 2006 and continuing until, and including January 30, 2008), without the prior written consent of the Company.
